» Articles » PMID: 25756799

Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential

Abstract

Galectin-1 (Gal-1)-binding to Gal-1 ligands on immune and endothelial cells can influence melanoma development through dampening antitumor immune responses and promoting angiogenesis. However, whether Gal-1 ligands are functionally expressed on melanoma cells to help control intrinsic malignant features remains poorly understood. Here, we analyzed expression, identity, and function of Gal-1 ligands in melanoma progression. Immunofluorescent analysis of benign and malignant human melanocytic neoplasms revealed that Gal-1 ligands were abundant in severely dysplastic nevi, as well as in primary and metastatic melanomas. Biochemical assessments indicated that melanoma cell adhesion molecule (MCAM) was a major Gal-1 ligand on melanoma cells that was largely dependent on its N-glycans. Other melanoma cell Gal-1 ligand activity conferred by O-glycans was negatively regulated by α2,6 sialyltransferase ST6GalNAc2. In Gal-1-deficient mice, MCAM-silenced (MCAM(KD)) or ST6GalNAc2-overexpressing (ST6(O/E)) melanoma cells exhibited slower growth rates, underscoring a key role for melanoma cell Gal-1 ligands and host Gal-1 in melanoma growth. Further analysis of MCAM(KD) or ST6(O/E) melanoma cells in cell migration assays indicated that Gal-1 ligand-dependent melanoma cell migration was severely inhibited. These findings provide a refined perspective on Gal-1/melanoma cell Gal-1 ligand interactions as contributors to melanoma malignancy.

Citing Articles

Glycosylation in the tumor immune response: the bitter side of sweetness.

Cao Y, Yi W, Zhu Q Acta Biochim Biophys Sin (Shanghai). 2024; 56(8):1184-1198.

PMID: 38946426 PMC: 11399423. DOI: 10.3724/abbs.2024107.


Galectin-1 overexpression induces normal fibroblasts translate into cancer-associated fibroblasts and attenuates the sensitivity of anlotinib in lung cancer.

Zhang L, Chen W, Li X, Wang G, Xing F, Zhu X Cell Adh Migr. 2024; 18(1):1-11.

PMID: 38557441 PMC: 10986763. DOI: 10.1080/19336918.2024.2335881.


Galectin functions in cancer-associated inflammation and thrombosis.

Kruk L, Braun A, Cosset E, Gudermann T, Mammadova-Bach E Front Cardiovasc Med. 2023; 10:1052959.

PMID: 36873388 PMC: 9981828. DOI: 10.3389/fcvm.2023.1052959.


Neoplastic signatures: Comparative proteomics of canine hepatobiliary neuroendocrine tumors to normal niche tissue.

Batts T, Sasaki E, Miller M, Sparago J, Bauer R, Paulsen D PLoS One. 2023; 18(1):e0280928.

PMID: 36696389 PMC: 9876354. DOI: 10.1371/journal.pone.0280928.


Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.

Lau L, Mohammed N, Dimitroff C Int J Mol Sci. 2022; 23(24).

PMID: 36555198 PMC: 9778980. DOI: 10.3390/ijms232415554.


References
1.
Marcos N, Pinho S, Grandela C, Cruz A, Samyn-Petit B, Harduin-Lepers A . Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res. 2004; 64(19):7050-7. DOI: 10.1158/0008-5472.CAN-04-1921. View

2.
Powell J, WHITNEY P . Endogenous ligands of rat lung beta-galactoside-binding protein (galaptin) isolated by affinity chromatography on carboxyamidomethylated-galaptin-Sepharose. Biochem J. 1984; 223(3):769-74. PMC: 1144361. DOI: 10.1042/bj2230769. View

3.
Iacobelli S, Arno E, DOrazio A, Coletti G . Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res. 1986; 46(6):3005-10. View

4.
Wang Z, Yan X . CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 2012; 330(2):150-62. DOI: 10.1016/j.canlet.2012.11.049. View

5.
Croci D, Cerliani J, DAlotto-Moreno T, Mendez-Huergo S, Mascanfroni I, Dergan-Dylon S . Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 2014; 156(4):744-58. DOI: 10.1016/j.cell.2014.01.043. View